IGKV2D-29 and ischemia: While most studies demonstrate a protective effect of A2A agonists after trauma/ischemia in SC, robust evidence from studies of brain indicates that A2A receptor genetic inactivation [18] and adenosine A2A antagonists protect against ischemia [19-22].